期刊文献+

凋亡相关基因产物Fas/APO-1和Bcl-2蛋白在肺癌组织中的表达及意义 被引量:2

Expression and significance of Fas/APO-1 and Bcl-2 protein in human lung cancer
原文传递
导出
摘要 目的 探讨凋亡相关基因Fas/APO1和Bcl2在肺癌发生发展中的作用。方法 采用免疫组织化学方法对65例肺癌组织和46例远离肺癌正常肺组织Fas/APO1和Bcl2蛋白的表达进行检测。结果 肺癌组织Fas/APO1蛋白阳性表达率(56.92%)明显低于正常肺组织的阳性表达率(82.61%)(P<0.01),而Bcl2蛋白阳性表达率(46.15%)明显高于正常肺组织的阳性表达率(6.52%)(P<0.01)。 Objective To investigate the role of Fas/APO 1 and Bcl 2 in oncogenesis and progression of lung cancer. Methods The expression of Fas/APO 1 and Bcl 2 protein were detected in 65 lung cancer tissues and 46 normal lung tissues by immunohistochemistry. Results The positive rate of Fas/APO 1 protein expression in lung cancer tissues was 56.92%, which was significantly lower than that in normal lung tissues(82.61%)(P<0.01). The positive rate of Bcl 2 protein expression was 46.15%. It was significantly higher than that in normal lung tissues(6.52%)(P<0.01).Conclusion Both Fas/APO 1 and Bcl 2 may play an role in the oncogenesis and progression of lung cancer.
机构地区 解放军
出处 《肺癌杂志》 1999年第1期17-19,共3页
关键词 肺肿瘤 基因表达 FAS APO-1 BCL-2基因 Lung neoplasms Gene expression Fas/APO 1 Bcl 2 gene
  • 相关文献

参考文献1

二级参考文献3

  • 1李宏军,中华外科杂志,1997年,35卷,59页
  • 2Yang E,Blood,1996年,88卷,386页
  • 3吴阶平,泌尿外科,1993年,479页

共引文献9

同被引文献21

  • 1孙龙,官泳松,周翔平,李肖.介入放射学在肿瘤基因治疗中的意义[J].中国介入影像与治疗学,2004,1(2):151-154. 被引量:7
  • 2焦旭东,陈方满.肺癌介入治疗现状综述[J].华北煤炭医学院学报,2006,8(6):771-773. 被引量:1
  • 3Mikaye M, Taki T, Hitomi S, et al. Correlation of expression of H/ Ley / Leb antigens with survival in patients with carcinoma of the lung [J]. N Engl J Med, 1992,327:14- 18.
  • 4Reed JC. Bcl-2 and the regulation of programmed cell death[J]. J Cell Biol, 1994,124:1-5.
  • 5Levine A. The p53 tumor-auppress or gene[J]. N Engl J Med, 1992, 326:1350 - 1352.
  • 6Folkman J. What is the evidence that tumors are angiogenesis dependant? [J]. J Nall Caaeer Inst,1989,82:4-6.
  • 7Hananhan D, Folkman J. Patterns and emerging mechanisms of the angiogenie switch during tumorigenesis[J]. CEU,1996,86:353-364.
  • 8Shimizu E, Na kamura Y, Mukai J, et al. Pharmacokinetics of bronchial artery infusion of mitomycin in patients with non-small cell lung cancer[J].. Eur J Cancer, 1991,27:1046.
  • 9Masuda H, Makita K, Nakajima T. Chest wall implanted reservoir for bronchial arterial infusion of antineoplastie agents in high-aged lung cancer patients[J]. Jpn J Thorae Cardiovasc Surg,1999,47:124.
  • 10Liu ZL. Profess in interventional therapy of lung cancer[ J]. Journal of Postgraduates of Medicine, 2001,24:12.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部